Sign In
Buy SNN
$29.36
-0.120 (-0.407%)
At Close: Jun 02, 2026
Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology business, is pleased to announce exciting new data from Professor Amit Gefen and his research group published in the International Wound
Smith+Nephew launches CORIOGRAPH™ Pre-Op Planning and Modeling Services for total shoulder arthroplasty
01:00pm, Wednesday, 01'st Oct 2025
Completes the CORIOGRAPH Services portfolio which also includes solutions for knee and hip arthroplasty Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the laun
Should Value Investors Buy Smith & Nephew SNATS (SNN) Stock?
10:41am, Thursday, 25'th Sep 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
SNN vs. SYK: Which Stock Is the Better Value Option?
12:40pm, Monday, 22'nd Sep 2025
Investors interested in stocks from the Medical - Products sector have probably already heard of Smith & Nephew (SNN) and Stryker (SYK). But which of these two companies is the best option for those l
Smith+Nephew unveils major clinical evidence and patient access updates for its REGENETEN™ Bioinductive Implant
08:00am, Thursday, 11'th Sep 2025
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces new evidence and market updates that highlight the clinical performance of its REGENETEN Bioinductive Implant an
Smith+Nephew extends Advanced Wound Bioactives portfolio with US launch of CENTRIO Platelet-Rich-Plasma System
10:16am, Wednesday, 03'rd Sep 2025
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of the CENTRIO Platelet-Rich-Plasma (PRP) System, a biodynamic hematogel derived from a patient's own
Are Investors Undervaluing Smith & Nephew SNATS (SNN) Right Now?
05:31pm, Tuesday, 02'nd Sep 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
SNN or SYK: Which Is the Better Value Stock Right Now?
12:41pm, Tuesday, 02'nd Sep 2025
Investors with an interest in Medical - Products stocks have likely encountered both Smith & Nephew (SNN) and Stryker (SYK). But which of these two stocks presents investors with the better value oppo
SNN vs. SYK: Which Stock Is the Better Value Option?
12:40pm, Friday, 15'th Aug 2025
Investors with an interest in Medical - Products stocks have likely encountered both Smith & Nephew (SNN) and Stryker (SYK). But which of these two stocks is more attractive to value investors?
Smith & Nephew: US bank upbeat after meetings with management
09:51am, Monday, 11'th Aug 2025
Citi has reiterated its buy rating on Smith & Nephew PLC (LSE:SN) following recent meetings with the company's CEO and CFO. The bank highlights a constructive tone around the business despite the deci
Smith & Nephew: Doing Better And Still Offers Value
11:37am, Thursday, 07'th Aug 2025
Smith & Nephew's interim results confirm solid progress, with revenue up 5% and strong cash flow growth, supporting my continued 'buy' rating. Dividend growth has resumed after years of stagnation, an
US bank ‘buy' on Smith & Nephew after better-than-expected results and $500m buyback
08:46am, Wednesday, 06'th Aug 2025
Citi has stuck with its ‘buy' call on Smith & Nephew PLC (LSE:SN) after the company delivered quarterly results that were, in Citi's words, “meaningfully better than expected”, and announced a
Smith & Nephew plc (SNN) Q2 2025 Earnings Call Transcript
10:06am, Tuesday, 05'th Aug 2025
Smith & Nephew plc (NYSE:SNN ) Q2 2025 Earnings Conference Call August 5, 2025 3:30 AM ET Company Participants Deepak S. Nath - CEO & Director John Terence Rogers - CFO & Executive Director Conference
Smith+Nephew jumps 14% on earnings beat and buyback
09:46am, Tuesday, 05'th Aug 2025
Smith & Nephew PLC (LSE:SN) shares surged 14% after the company reported robust revenue and profit growth, and announced a $500 million share buyback to be launched in the second half of the year. The
Top 2 Health Care Stocks You May Want To Dump In Q3
09:11am, Tuesday, 05'th Aug 2025
As of Aug. 5, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
